Developmental population pharmacokinetics of caffeine in Chinese premature infants with apnoea of prematurity: A post‐marketing study to support paediatric labelling in China-Reference-Cited by-同舟云学术

Developmental population pharmacokinetics of caffeine in Chinese premature infants with apnoea of prematurity: A post‐marketing study to support paediatric labelling in China

Published:2020-07-27 Issue:3 Volume:87 Page:1155-1164
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Gao Xiang‐Bo¹,Zheng Yi²,Yang Fan²,Wang Chen‐Hong³,Jiang Zhou‐Hong¹,Wu Yue‐E²,Jacqz‐Aigrain Evelyne⁴⁵^ORCID,Ni Shao‐Qing⁶,Zhao Wei²⁷⁸^ORCID

Affiliation:

1. Department of Pharmacy Children's Hospital, Zhejiang University School of Medicine Hangzhou Zhejiang Province China

2. Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Cheeloo College of Medicine Shandong University Jinan China

3. Department of Neonatal Intensive Care Unit Children's Hospital, Zhejiang University School of Medicine Hangzhou Zhejiang Province China

4. Department of Pediatric Pharmacology and Pharmacogenetics Hôpital Robert Debré, APHP Paris France

5. Sorbonne Paris Cité University Paris Diderot Paris France

6. Clinical Trial Institute Children's Hospital, Zhejiang University School of Medicine Hangzhou Zhejiang Province China

7. Department of Clinical Pharmacy The First Affiliated Hospital of Shandong First Medical University Jinan China

8. Clinical Research Center The First Affiliated Hospital of Shandong First Medical University Jinan China

Funder

China Postdoctoral Science Foundation

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14483

Reference36 articles.

1. Apnea in premature infants: monitoring, incidence, heart rate changes, and an effect of environmental temperature;Daily WJ;Pediatrics,1969

2. Morbidity and mortality of infants weighing less than 1,000 grams in an intensive care nursery;Alden ERMT;Pediatrics,1972

3. Caffeine Therapy for Apnea of Prematurity

4. Use of Methylxanthine Therapies for the Treatment and Prevention of Apnea of Prematurity

5. Theophylline or Caffeine: Which Is Best for Apnea of Prematurity?

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population Pharmacokinetics of Caffeine in Neonates with Congenital Heart Disease and Associations with Acute Kidney Injury;The Journal of Clinical Pharmacology;2023-11-22

2. A CAFEÍNA COMO DROGA DE PRIMEIRA ESCOLHA NO TRATAMENTO DE RECÉM-NASCIDOS PREMATUROS COM APNEIA;REVISTA FOCO;2023-11-21

3. Temporal profile of adverse drug reactions and associated clinical factors: a prospective observational study in a neonatal intensive care unit;BMJ Open;2023-08

4. Effect of early preventive use of caffeine citrate on prevention together with treatment of BPD within premature infants and its influence on inflammatory factors;Biotechnology and Genetic Engineering Reviews;2023-04-20

5. Population pharmacokinetic modeling of caffeine in preterm infants with apnea of prematurity: New findings from concomitant erythromycin and AHR genetic polymorphisms;Pharmacological Research;2022-10